Carregant...
Barriers to treatment of failed or interferon ineligible patients in the era of DAA: single center study
BACKGROUND/AIMS: Interferon-based treatment is not appropriate for a large number of patients with chronic hepatitis C for various medical and social reasons. Newly developed directly acting antivirals (DAAs) have been used to treat chronic hepatitis C without severe adverse effects and have achieve...
Guardat en:
| Publicat a: | Clin Mol Hepatol |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
The Korean Association for the Study of the Liver
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5381840/ https://ncbi.nlm.nih.gov/pubmed/28259115 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3350/cmh.2016.0052 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|